Aurobindo Ramps Up In Biosimilars With UK Bevacizumab Nod

CuraTeQ Subsidiary Receives MHRA Approval For Bevqolva Rival To Avastin

 
• By Dave Wallace
  
Aurobindo has picked up an MHRA nod for bevacizumab (Shutterstock)

More from Biosimilars

More from Generics Bulletin